Weekly Digest – April 2024 Weekly Digest – April 2024 8 Apr 2024: Genmab to acquire ADC maker ProfoundBio Genmab to acquire ProfoundBio for $1.8 billion Acquisition includes three clinical-stage drug candidates: Rinatabart sesutecan targets folate receptor α in ovarian […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id